Side-by-side comparison of AI visibility scores, market position, and capabilities
International tobacco leader transformed by IQOS heated tobacco (32.4M users) and ZYN nicotine pouches; $37.9B FY2024 revenue; 65%+ smoke-free revenue target; $16B Swedish Match acquisition 2022.
Philip Morris International (PMI) is the world's largest international tobacco and smoke-free products company, spun off from Altria Group in 2008 and headquartered in Stamford, Connecticut, trading on NYSE (PM). PMI sells products in approximately 180 markets outside the United States and generated approximately $37.9 billion in net revenues for FY2024 under CEO Jacek Olczak, who has accelerated the company's transformation toward a smoke-free future. PMI's strategic pivot is anchored by IQOS—a heated tobacco system that heats tobacco sticks (HEETS/Terea) to generate nicotine-containing aerosol without combustion—which has achieved category-creating success in Japan, Italy, Germany, and Eastern Europe with approximately 32.4 million users globally as of 2024.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.